At present writing, all everyone is talking about is whether they’ve gotten their shot or when they’re getting their shot, and where they got it, what kind of shot they’re getting or what kind they would prefer. They are posting on social media about the difficulty of getting an appointment soon enough, close enough to
We’ve all learned a lot in the last 12 months. Personally and in our business lives. We’ve all learned to “pivot” (the designated word of the pandemic), and we’ve heard time and again “you’re on mute.” Both defined the new world we found ourselves in, assuming we were fortunate enough to have a job, could
As the U.S. health care landscape continues to evolve amid the COVID-19 pandemic, drug store retailers are seeking to become the first port of call for patients. To achieve this and capitalize on the rapid changes in health care, they are refining their strategies for both online and off-line channels. Transforming retail stores to expand
For the past three years, I’ve had the privilege of working alongside some of the most incredible women as chair of WE. Today I’m proud to introduce WE’s newest chair, Michele Muhammad, chief marking officer of DSE Healthcare. Michele’s election marks Phase 2 for the community. Michele has big plans that will further enhance our
You can read the full April 26 print issue of Chain Drug Review in its entirety, along with years of archives. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!
It would be an understatement to say that COVID-19 launched the retail industry into challenging times. What began as additional safety and cleaning procedures including social distancing measures in-store quickly spiraled into large-scale changes that required retailers to add an online presence, if they didn’t have one already, and cater to consumers in new (often
NEW YORK — Now that more Americans are getting vaccinated in the race to build up enough herd immunity to beat the pandemic, questions are mounting as to how long the protection from those shots will last. Along with the unknown duration of immunity the shots offer, there’s also the worry of emerging variants that
The impact of the pandemic has transformed the pharmacy team, shifting not only day-to-day tasks but also how they engage with patients. Many pharmacists now find themselves shifting their approach to connect with patients through virtual exchanges, often helping them manage medication therapy and guiding them through complex patient care services via video. They are
At this week’s NACDS Annual Meeting, Rick Keyes will conclude what is probably the most unusual and challenging term experienced by any of the association’s chairmen. Thrust into the role a year earlier than planned, when Richard Ashworth left Walgreens Boots Alliance to join Tivity Health, Keyes was tasked with guiding NACDS through myriad trials
As we, among others of lesser renown, have repeatedly pointed out, this year’s NACDS Annual Meeting will differ from those that have preceded it. For one obvious reason. It will be conducted virtually. That being the case, we thought we would help you out by offering — indeed insisting on — five appointments you, whether
MANHASSET, N.Y. — In her 35 years as a pharmacist, Helen Maser has never experienced times as challenging as these — or as rewarding. When the coronavirus began spreading in March 2020, and as it became clear that it was a full-blown pandemic, pharmacists like Maser kicked into high gear and demonstrated why they are
You can read the full April 5 print issue of Chain Drug Review in its entirety, along with years of archives. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!
As more Americans get vaccinated against COVID-19 every day and hope for a restoration of pre-pandemic conditions intensifies, pharmacy operators are thinking about how their stores will fit into the retail landscape as the new normal takes shape. Consumer behavior has changed considerably over the past 12 months, as restrictions on businesses and risk aversion
The chain drug industry has yet to meet Karen Lynch. But that’s about to change — for the better. In an industry that has made its considerable reputation, at least in part, on the strength of its leaders, Lynch is both a logical extension of that reputation and a pleasant surprise for those who have
